E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation
PLOS Genetics · 2025
DOI: 10.1371/journal.pgen.1011781 ↗Kurz gefasst
Fachartikel in der Zeitschrift PLOS Genetics, 2025. Verfasst von Miguel Ramirez Moreno und 5 weiteren Autor:innen. Beteiligte Einrichtung: School of Biosciences, University of Sheffield, Sheffield, United Kingdom. Hauptthemen laut MEDLINE: ErbB Receptors, STAT Transcription Factors, Endocytosis, Cadherins. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Biotechnology and Biological Sciences Research Council.
Abstract (Originalsprache)
Signalling molecules often contribute to several downstream pathways that produce distinct transcriptional outputs and cellular phenotypes. One of the major unanswered questions in cell biology is how multiple activities of signalling molecules are coordinated in space and time in vivo. Here, we focus on the Signal Transducer and Activator of Transcription (STAT) protein as a paradigm of signalling molecules involved in several independent signalling pathways. Using Drosophila wing discs as an in vivo model, we demonstrate an interplay of at least three STAT activities in this tissue. In addition to the ‘canonical’ pathways, in which STAT is phosphorylated and activated by Janus Kinases, STAT is involved in two ‘non-canonical’ pathways. In one pathway, STAT is activated by the Epidermal Growth Factor Receptor (EGFR), promoting apoptosis. In the other, it binds the Heterochromatin Protein 1 (HP1) to enhance heterochromatin formation. We provide evidence that while the ‘canonical’ STAT signalling is dominant over ‘non-canonical’ pathways, EGFR:STAT and HP1:STAT pathways compete for the availability of unphosphorylated STAT. We also describe a central role for the cell-cell adhesion protein E-cadherin, with both EGFR and STAT colocalising with E-cadherin at cell-cell junctions and on intracellular vesicles. We show that elevated intracellular E-cadherin promotes EGFR:STAT pathway leading to apoptosis, which is prevented by inhibiting E-cad endocytosis. Taken together, we conclude that E-cadherin controls the balance between two non-canonical STAT activities. We hypothesise that this balance represents a tumour-suppressive mechanism, in which junctional disassembly in dysregulated epithelial-to-mesenchymal transitions would shift this balance towards the EGFR:STAT signalling to promote apoptosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- School of Biosciences, University of Sheffield, Sheffield, United Kingdom.
- Nonacus Limited, Birmingham, United Kingdom.
ORCID-Profile: Miguel Ramirez Moreno, Eleanor Jacobsen, Martin P Zeidler, Natalia A Bulgakova
Förderung
- Biotechnology and Biological Sciences Research Council
Zitieren
APA
Ramirez Moreno, M., Quinton, A., Jacobsen, E., Stempor, P. A., Zeidler, M. P., & Bulgakova, N. A. (2025). E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation. PLOS Genetics. https://doi.org/10.1371/journal.pgen.1011781
Vancouver
Ramirez Moreno M, Quinton A, Jacobsen E, Stempor PA, Zeidler MP, Bulgakova NA. E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation. PLOS Genetics. 2025. doi:10.1371/journal.pgen.1011781
BibTeX
@article{RamirezMoreno2025,
author = {Ramirez Moreno, Miguel and Quinton, Amy and Jacobsen, Eleanor and Stempor, Przemyslaw A and Zeidler, Martin P and Bulgakova, Natalia A},
title = {E-cadherin endocytosis promotes non-canonical EGFR:STAT signalling to induce cell death and inhibit heterochromatinisation},
journal = {PLOS Genetics},
year = {2025},
doi = {10.1371/journal.pgen.1011781}
}
EUVIMED